We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
1026
iShares Core S&P Mid-Cap ETF
IJH
$122B
$530K ﹤0.01%
19,275
NATR icon
1027
Nature's Sunshine
NATR
$230M
$530K ﹤0.01%
38,477
+12,582
+49% +$199K
KYTH
1028
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$530K ﹤0.01%
+13,335
New +$597K
CDR
1029
DELISTED
Cedar Realty Trust, Inc
CDR
$525K ﹤0.01%
13,030
+3,348
+35% +$139K
LOGI icon
1030
Logitech
LOGI
$14.5B
$523K ﹤0.01%
+35,000
New +$537K
PAMT
1031
PAMT Corp
PAMT
$270M
$522K ﹤0.01%
105,080
+87,784
+508% +$443K
IJK icon
1032
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.3B
$520K ﹤0.01%
13,600
KMR
1033
DELISTED
KINDER MORGAN MANAGEMENT LLC
KMR
$520K ﹤0.01%
7,628
EMIF icon
1034
iShares Emerging Markets Infrastructure ETF
EMIF
$13.2M
$516K ﹤0.01%
15,390
+2,920
+23% +$94.3K
HLF icon
1035
Herbalife
HLF
$1.25B
$516K ﹤0.01%
18,000
+400
+2% +$13.2K
TCX icon
1036
Tucows
TCX
$115M
$515K ﹤0.01%
+40,706
New +$538K
IMCG icon
1037
iShares Morningstar Mid-Cap Growth ETF
IMCG
$3.96B
$512K ﹤0.01%
21,180
RDI icon
1038
Reading International Class A
RDI
$46.5M
$507K ﹤0.01%
69,200
+9,240
+15% +$68.7K
ARLP icon
1039
Alliance Resource Partners
ARLP
$3.36B
$505K ﹤0.01%
12,000
FL
1040
DELISTED
Foot Locker
FL
$503K ﹤0.01%
10,700
-16,400
-61% -$681K
IWP icon
1041
iShares Russell Mid-Cap Growth ETF
IWP
$19B
$502K ﹤0.01%
11,708
DAR icon
1042
Darling Ingredients
DAR
$10.5B
$501K ﹤0.01%
25,000
URS
1043
DELISTED
URS CORP
URS
$498K ﹤0.01%
10,600
+1,600
+18% +$77.5K
FRME icon
1044
First Merchants
FRME
$2.62B
$496K ﹤0.01%
22,900
+19,500
+574% +$413K
MAC icon
1045
Macerich
MAC
$6.35B
$495K ﹤0.01%
7,941
HBIO icon
1046
Harvard Bioscience
HBIO
$36.4M
$489K ﹤0.01%
10,310
+20
+0.2% +$910
ZEP
1047
DELISTED
ZEP INC COM STK (DE)
ZEP
$487K ﹤0.01%
27,500
-12,721
-32% -$219K
STAG icon
1048
STAG Industrial
STAG
$7.16B
$482K ﹤0.01%
+20,000
New +$446K
HNH
1049
DELISTED
Handy & Harman Holdings Ltd.
HNH
$481K ﹤0.01%
21,861
-1,409
-6% -$29.2K
FLRN icon
1050
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.95B
$480K ﹤0.01%
15,690
+2,680
+21% +$82K

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.